Silence-Logo-FINAL-rgb.png
Silence Therapeutics Welcomes Deep Track Capital as New Shareholder
December 01, 2021 07:00 ET | Silence Therapeutics plc
1 December 2021 LONDON, Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA)...